Evolution of the Average Target: Dermapharm Holding SE

Evolution of the Target Price: Dermapharm Holding SE

Changes in Analyst Recommendations: Dermapharm Holding SE

a5166cd230020b.LWXRG5J_lYbPs4-3qNowFN8scRo1jld5RCQVffPSaRo.XQqQaKsM0uy717zd7Y1dZbdfP0pN5zoMCGFbEd6HKCpgEOh-xgfe1L362g~a464fa61057e1f0274a1fa8609d1f55b
09-03 Dermapharm Holding SE : Jefferies remains Neutral ZD
08-27 Dermapharm Holding SE : Receives a Buy rating from Berenberg ZD
08-25 Dermapharm Holding SE : Jefferies gives a Neutral rating ZD
08-25 Jefferies keeps Dermapharm at 'Hold', target €44 DP
08-11 Dermapharm Holding SE : Jefferies remains Neutral ZD
07-17 Dermapharm shares slide, BaFin probes annual financial statements DP
05-27 DERMAPHARM : Jefferies remains Neutral ZD
05-27 Jefferies raises Dermapharm target to 44 euros - 'Hold' DP
05-14 Dermapharm hits highest level since August 2022 DP
05-14 DERMAPHARM : Berenberg reaffirms its Buy rating ZD
05-13 Dermapharm Confirms Its Guidance After a Strong First Quarter Zonebourse
03-31 Alstom gains momentum, Inventiva underperforms Zonebourse
03-31 DERMAPHARM : Jefferies reiterates its Neutral rating ZD
03-10 DERMAPHARM : Jefferies gives a Neutral rating ZD
03-10 Dermapharm in the green as full-year EBITDA improves Zonebourse
03-10 DERMAPHARM : Jefferies gives a Neutral rating ZD
03-09 Jefferies Maintains 'Hold' Rating on Dermapharm - Target 34 Euros DP
11-27 DERMAPHARM : Jefferies reiterates its Neutral rating ZD
11-13 DERMAPHARM : Jefferies reiterates its Neutral rating ZD
25-09-08 DERMAPHARM : Gets a Neutral rating from Jefferies ZD
25-08-28 Jefferies downgrades affect Cancom, Vorwerk, and Dermapharm DP
25-08-28 Jefferies Downgrades Dermapharm to 'Hold', Slashes Price Target to 34 Euros DP
25-08-28 DERMAPHARM : Jefferies lowers his opinion and switches to Neutral ZD
25-08-26 DERMAPHARM : Warburg Research reiterates its Neutral rating ZD
25-08-26 Warburg Research leaves Dermapharm at 'Hold' – target price €41 DP

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+31.11%
+14.96%
+2.93%
+5.55%
+5.2%
+9.33%
+26.46%
+0.53%
+10.16%
+5.35%
Average +11.16%
Weighted average by Cap. +9.47%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
38.90EUR
Average target price
51.00EUR
Spread / Average Target
+31.11%
High Price Target
60.00EUR
Spread / Highest target
+54.24%
Low Price Target
44.00EUR
Spread / Lowest Target
+13.11%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. DMP Stock
  4. Consensus Dermapharm Holding SE
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!